BOSTON, July 8, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that
the Company intends to publish first quarter fiscal year 2025
financial results at 6:00 am ET on Thursday,
August 8, 2024. The Company will hold a conference call with
investors and analysts to discuss results and answer questions at
8:00 am ET on August 8, 2024.
The call can be accessed via teleconference at: Q1 2025
Haemonetics Corporation Earnings Conference Call. Once
registration is completed, participants will receive a dial-in
number along with a personalized PIN to access the call. While not
required, it is recommended that participants join 10 minutes prior
to the event start.
A live webcast of the call can be accessed on Haemonetics'
investor relations website. Webcast
Link: https://edge.media-server.com/mmc/p/qeo7r49a
A replay of the conference call and webcast will be available
for one year beginning on August 8,
2024 at 11:00 am ET using the
conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated
to providing a suite of innovative medical products and solutions
for customers, to help them improve patient care and reduce the
cost of healthcare. Our technology addresses important medical
markets: blood and plasma component collection, the surgical suite
and hospital transfusion services. To learn more about Haemonetics,
visit www.haemonetics.com.
|
Investor
Contacts:
|
|
|
Olga Guyette, Vice
President-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
|
(781) 356-9763
|
(203)
733-4987
|
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
|
Media
Contact:
|
|
|
Josh Gitelson, Sr.
Director-Global
Communications
|
|
|
(781)
356-9776
|
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2025-results-august-8-2024-302191202.html
SOURCE Haemonetics Corporation